Metrics as of 10/16/2026, 08:33 AM (Berlin time), refresh in progress.
Gilead Sciences Stock
Gilead Sciences, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Daniel O'Day
- Employees
- 17,000
- Market cap
- $270.3 B
- IPO
- 07/01/2026
Gilead Sciences, Inc. is a global biopharmaceutical enterprise headquartered in Foster City, USA. Founded in 1987, the company employs approximately 17,000 employees. Its core business involves discovering, developing, and commercializing innovative medications to address critical health needs across various severe…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Gilead Sciences stock: price history
1D
-1.1%
1W
+3.1%
1M
+5.3%
6M
+11.8%
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Gilead Sciences
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
7,946
Dividends
Comparable stocks
Frequently asked questions about Gilead Sciences stock
What does Gilead Sciences do?
Gilead Sciences, Inc. is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Daniel O'Day, the company employs around 17,000 people.
The IPO was on 07/01/2026; the stock trades on TSX under the ticker GILD.TO.
Does Gilead Sciences pay a dividend?
Yes. The last dividend was CA$0.17 per share, ex-date 15/09/2026, paid on 07/10/2026.
Which stocks are comparable to Gilead Sciences?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get Gilead Sciences stock analyzed?
Clicking "Analyze stock" lets five strategies assess Gilead Sciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.